Abstract: The present disclosure relates generally to terpene glycosides, such as certain such compounds extracted from Stevia rebaudiana Bertoni, Rubus suavissimus, or Siraitia grosvenorii. The disclosure also provides for the use of such compounds as food ingredients, flavors, and sweeteners, and related methods. The disclosure also provides ingestible compositions comprising such compounds, as well as processes for extracting such compounds selectively from certain plant sources.

Abstract: Syringe carriers for medicament delivery devices are described where a medicament delivery device sub-assembly extending along a longitudinal axis from a proximal end to a distal end is described having a tubular housing, a tubular syringe carrier inside the housing and a syringe inside the syringe carrier. The syringe includes a needle shield and a medicament container comprising a shoulder. The housing includes a flexible arm extending in the axial direction relative to the longitudinal axis, the flexible arm having an inwardly extending protrusion arranged in a gap between the shoulder and the needle shield. The syringe carrier has a proximal portion and a distal portion, and the proximal portion is arranged adjacent to the flexible arm of the housing so that movement of the flexible arm of the housing in a radial direction relative to the longitudinal axis is restricted by the proximal portion of the syringe carrier.

Abstract: The present disclosure generally provides uses of certain mixed hydroxy- and methoxy-substituted flavones (HMFs) to reduce bitterness, astringency, or sourness, or to enhance sweetness of a ingestible composition, such as a flavored food or beverage product. In some embodiments, the disclosure provides uses of the HMFs disclosed herein to reduce the unpleasant taste of limonin, nomelin, or naringin, which can be present at elevated levels in certain citrus products.

Abstract: This application describes syringe carriers for medicament delivery devices such as autoinjectors. In particular, an example syringe carrier is tubular and extends along a longitudinal axis from a proximal end to a distal end, the syringe carrier comprising a base section at the distal end of the syringe carrier, the base section having a fixed circumference, at least one arm extending towards the proximal end of the syringe carrier from the base section, and an expandable ring attached to the proximal end of the at least one arm, wherein the ring extends entirely around the longitudinal axis of the syringe carrier in the circumferential direction. Various other syringe carriers and associated medicament delivery devices and methods are described.

Abstract: A display panel and a display device are provided. The display panel includes a first optical refraction layer and a second optical refraction layer. The first optical refraction layer includes a plurality of openings. The second refraction layer is filled in the plurality of openings. A refractive index of the second optical refraction layer is greater than a refractive index of the first optical refraction layer. Furthermore, nanoparticles are further disposed in the second optical refraction layer. When light passes through, the first optical refraction layer and the second optical refraction layer can effectively improve transmittance rates of the light. Meanwhile, the nanoparticles can further act on the light, thereby effectively increasing a light extraction rate of the display panel and improving display effect of the display panel.

Abstract: The present disclosure generally provides uses of certain mixed hydroxy- and methoxy-substituted flavanones (HMFs) to reduce bitterness, astringency, or sourness, or to enhance sweetness of a ingestible composition, such as a flavored food or beverage product. In some embodiments, the disclosure provides uses of the HMFs disclosed herein to reduce the unpleasant taste of limonin, nomelin, or naringin, which can be present at elevated levels in certain citrus products.

Abstract: A medicament delivery member housing assembly is disclosed that extends along an axis in a longitudinal direction from a proximal end to a distal end. The medicament delivery member housing assembly has a housing, a medicament delivery member, a proximal shield, and a distal shield. The housing can have a body and a flexible arm, the flexible arm extending in the longitudinal direction from a proximal end moveable relative to the body to a distal end attached to the body, wherein the flexible arm has a first surface facing towards the proximal end of the medicament delivery member housing assembly and a second surface facing in a radial direction relative to the axis. The proximal shield extends around a first end of the medicament delivery member, the proximal shield can have a surface facing towards the distal end of the medicament delivery member housing assembly to interact with the first surface of the housing during use.

Abstract: A cassette unit sub-assembly for a medicament delivery device, the sub-assembly comprising: a body extending along a longitudinal axis from a proximal end to a distal end; a delivery member guard coaxially attached to the body and being axially movable relative to the body along the longitudinal axis; a lock member attached to the body; the lock member is movable relative to the delivery member guard between a locked position and an unlocked position; the lock member comprises a distally directed surface adjacent to a proximally directed surface of the delivery member guard in the locked position; and the distally directed surface of the lock member is spaced apart in a circumferential direction relative to the longitudinal axis from the proximally directed surface of the delivery member guard in the unlocked position.

Abstract: A detection system and method for the migrating cell is provided. The system is configured to detect a migrating cell combined with an immunomagnetic bead. The system includes a platform, a microchannel, a magnetic field source, a coherent light source and an optical sensing module. The microchannel is configured to allow the migrating cell to flow in it along a flow direction. The magnetic field source is configured to provide magnetic force to the migrating cell combined with the immunomagnetic bead. The magnetic force includes at least one magnetic force component and the magnetic force component is opposite to the flow direction of the microchannel. The coherent light source is configured to provide the microchannel with the coherent light. The optical sensing module is configured to receive the interference light caused by the coherent light being reflected by the sample inside the microchannel.

Abstract: A device includes: a complementary transistor including: a first transistor having a first source/drain region and a second source/drain region; and a second transistor stacked on the first transistor, and having a third source/drain region and a fourth source/drain region, the third source/drain region overlapping the first source/drain region, the fourth source/drain region overlapping the second source/drain region. The device further includes: a first source/drain contact electrically coupled to the third source/drain region; a second source/drain contact electrically coupled to the second source/drain region; a gate isolation structure adjacent the first and second transistors; and an interconnect structure electrically coupled to the first source/drain contact and the second source/drain contact.

Abstract: Provided herein is a method of improving the taste profile of a glucosylated terpene glycoside (GTG).

Abstract: A sub-assembly for a medicament delivery device cassette unit, the sub-assembly having a body extending along a longitudinal axis from a proximal end to a distal end; a delivery member guard coaxially attached to the body and being axially movable relative to the body along the longitudinal axis; a latch adjacent to the delivery member guard and axially movable relative to the body; and a lock member attached to the body; the lock member is movable relative to the latch between a locked position and an unlocked position; the lock member has a distally directed surface facing a proximally directed surface of the latch in the locked position; and wherein the distally directed surface of the lock member is further apart from the proximally directed surface of the latch in the unlocked position than in the locked position.

Abstract: Authentication management by receiving a request to initiate an authentication from a computing device of a user, directing the request to a selected authentication service of a plurality of authentication services, wherein the selected authentication service is determined dynamically based on respective authentication metrics of the plurality of authentication services, receiving authentication information via the selected authentication service, and authenticating the user based on the received authentication information.

Abstract: Methods, computer program products, systems are provided for securely performing electronic transactions over a network. An acoustic wave signal is received. The acoustic wave signal is encoded with at least an identifier of a payer of a transaction and transaction information of the transaction. The identifier of the payer and the transaction information is then obtained from the acoustic wave signal. A bone conduction characteristic of the payer is retrieved based on the identifier of the payer and based on the received bone conduction characteristic of the payer, the payer is verified. Completion of the transaction is allowed based on the transaction information in response to the payer being verified.

Abstract: The present disclosure generally provides conjugates diynes, particularly 6,8-diyne amides, and the use of such compounds and related compounds as flavor modifiers. In some aspects, the disclosure provides compositions that include such conjugated diynes, such as compositions that include such conjugated diynes and one or more additional compounds, such as a sweetener, salt, a glutamate, an arginate, and the like. In some other aspects, the disclosure provides methods of reducing or eliminating the amount of sweetener, salt, glutamate, or arginate in a food or beverage product.

Abstract: The present disclosure relates generally to malonyl steviol glycosides and the use of such compounds for various comestible uses, such as sweetening a flavored product or enhancing the sweetness of another sweetener. In some aspects, the disclosure provides certain compositions that include such malonyl steviol glycosides, such as compositions that include such malonyl steviol glycosides and one or more other sweeteners. In some other aspects, the disclosure provides methods of reducing the caloric content of a flavored article, such as a flavored food or beverage product, or an oral care product.

Abstract: Authentication management by receiving a request to initiate an authentication from a computing device of a user, directing the request to a selected authentication service of a plurality of authentication services, wherein the selected authentication service is determined dynamically based on respective authentication metrics of the plurality of authentication services, receiving authentication information via the selected authentication service, and authenticating the user based on the received authentication information.

Abstract: The present disclosure generally provides the use glucosylated natural steviol glycosides (GSGs) to reduce certain undesirable taste notes common to oral care products. In related aspects, the disclosure provides compositions that comprise GSGs and one or more ingredients that give rise to certain undesirable taste notes. In some embodiments, such compositions are in the form of a food product, a beverage product, or an oral care product, such as a toothpaste, a mouthwash, a tooth-whitening composition, and the like.

Abstract: Techniques for hierarchical encryption for data storage are disclosed, in one or more embodiments. These techniques include parsing an electronic database storage request, based on the syntax of the request, to identify a plurality of request elements and determining, using one or more trained machine learning (ML) models, one or more sensitivities associated with the plurality of request elements. The techniques further include identifying one or more encryption techniques for the plurality of request elements based on the one or more sensitivities, encrypting data associated with the database storage request using the identified one or more encryption techniques, and storing the encrypted data and one or more associated encryption keys in an electronic database, using the electronic database storage request.

Abstract: A cassette is disclosed for receiving a medicament container, the cassette having a medicament delivery member; a guard for covering the medicament delivery member; a shell movable between a proximal shell position where movement of the guard is prevented by the shell, and a distal shell position where the guard is exposed from the shell; a biasing device arranged to force the shell towards the distal shell position; a blocking device movable from a blocking position where the shell is blocked from moving to the distal shell position, to a releasing position where the shell is released; and a locking device movable from a first position to a second position; wherein the blocking device and the locking device are arranged such that movement of the locking device from the first position to the second position causes the blocking device to move from the blocking position to the releasing position.